DXC Technology (NYSE: DXC), a leading information technology services and consulting company, has reported results for the first quarter of fiscal 2025.
- Total revenue came in at $3.24 billion in the first three months of fiscal 2025, down 6%; on an organic basis, revenue dropped 4%
- Q1 earnings, on a per-share basis, were $0.14, compared to $0.17 in the prior year quarter; Adjusted earnings per share were $0.74, up 17%
- Net income declined by 40% from last year to $25 million in Q1, with a corresponding margin of 0.8%
- The company delivered operating cash flow of $238 million in the June quarter, up 87%; Free Cash Flow was $45 million
- The management raised the low end of its full-year adjusted EBIT margin outlook range by 50 basis points to 6.5% – 7.0%
- The low end of the full-year adjusted earnings per share guidance range has been increased by $0.25 to $2.75 – $3.00
- The company also raised its full-year free cash flow outlook by $50 million to approximately $450 million
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Darden Restaurants (DRI) Q2 2025 Earnings: Key financials and quarterly highlights
Darden Restaurants, Inc., (NYSE: DRI) reported its second quarter 2025 earnings results today. Total sales increased 6% year-over-year to $2.9 billion. Consolidated same-restaurant sales increased 2.4%. Net earnings were $215.1
MU Earnings: Highlights of Micron’s Q1 2025 report
Chipmaker Micron Technology Inc. (NASDAQ: MU) Wednesday announced financial results for the first quarter of 2025, reporting an increase in revenues. The company reported adjusted earnings of $1.79 per share
“Gelteq has been continuously evolving to expand applications and audiences”
Gelteq Limited (NASDAQ: GELS) is a healthcare company specializing in the development and manufacturing of edible gel products, with a focus on areas like pharmaceuticals, nutraceuticals, pet care, and sports
